Siddhi Parikh
About Siddhi Parikh
Siddhi Parikh is a Pharmacovigilance Scientist at Bristol Myers Squibb in Summit, New Jersey, with over a decade of experience in the pharmaceutical industry, including roles at Novo Nordisk, Pfizer, and CVS Health.
Title
Siddhi Parikh is a Pharmacovigilance Scientist currently employed at Bristol Myers Squibb in Summit, New Jersey, United States. In this role, she is involved in monitoring, evaluating, and improving drug safety by systematically assessing adverse events and ensuring compliance with regulatory requirements and standards.
Company
Siddhi Parikh is currently associated with Bristol Myers Squibb, a global biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for patients in various therapeutic areas including oncology, immunology, cardiovascular, and fibrosis.
Education and Expertise
Siddhi Parikh holds a Doctor of Pharmacy (Pharm.D.) degree from the University of the Sciences in Philadelphia. She completed her pharmacy education from 1999 to 2005. Her advanced degree provides a robust clinical foundation essential for her pharmacovigilance work, ensuring drug safety and efficacy.
Work Experience at Major Pharmaceutical Companies
Siddhi Parikh has accumulated extensive experience in the pharmaceutical industry, primarily focused on pharmacovigilance and safety surveillance. She has served in key roles at several prominent pharmaceutical companies. At Novo Nordisk, she operated as a Case Processing Specialist from 2015 to 2021 in Princeton, New Jersey. Prior to that, she worked as a Safety Surveillance Associate at Pfizer from 2011 to 2015 in Peapack, NJ. Her career began as a Staff Pharmacist at CVS Health, where she worked from 2006 to 2011 in Perkasie, PA.
Career Transition and Development
Siddhi Parikh transitioned from a foundational role as a Staff Pharmacist at CVS Health to increasingly specialized positions in pharmacovigilance and drug safety. This evolution demonstrates her adaptability and dedication to advancing in the field of drug safety. Her experience across different segments of the pharmaceutical industry underscores her comprehensive understanding of both clinical and regulatory aspects of pharmacovigilance.